Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ffs, it was a simple question in response to a fascinating personal account about what he gave his dog for tumors, which is by the way a well known dietary supplement.
Just because someone replied and asked him a question doesn’t mean they’re going to go start treating themselves or animals with it without much more research.
That’s honestly very fascinating about your dog and the tumors. Did you just give him an over the counter Artmisinin like you can get on Amazon as a supplement? How did you know how much to give him? And then how much as maintenance after they went away? I’ve lost pets in the past to tumors.
I wouldn’t call most of what goes on here whining. Most is back and forth banter and being open on opinions one way or another bc most of us have gotten used to seeing the same people here for years now and just post thoughts casually. I guess for newer members it can come off as whining. I think most are simply longs venting built up frustration bc many feel we should be further along based on what the company led us to believe with various statements, tweets, etc.
Which also isn’t occurring. This pps has been in the same tight .04 range for 95% of the last two plus years. The Timothy Sykes group is the only one large enough to have affected this pps at times otherwise. And they’ve been well known to have pumped and dumped this multiple times. So they most likely account for the majority of the other 5% swings.
No one said anything about what we sold or didn’t sell on the way to .95. As usual people just assume that those of us still holding sub penny shares rode it all the way up and back down. Maybe some did. Many others sold some and kept some long. Does that mean we’re supposed to be happy with the progress since then with our remaining large amounts of long shares? Get real.
Lmfao imagine thinking a partnership with Regeneron for our Covid mab wouldn’t be a massive step forward for not only this company but shareholders investments as well. Not even possible to take you serious at this point.
I will. But prob with half the shares if that happens. I didn’t hold this long with all this bs for even .50 lol.
Let’s hope they have something big like Renegeron collab news. Idk what else could possibly move this to .50 unless it’s a buyout.
I have no idea what you’re rambling about. My post was about the delusions that this .04 cent otc stock is shorted by board members or other regular retail bc some voice their frustration here.
Actually that’s exactly what most real longs sounds like these days, bc we’re sick to f**k of how this has played out for nearly 3 years. And I know Rockie is a long bc he’s been here posting as long as I have, unlike majority of the ones I see here posting these days.
It’s hilarious how naive the majority of people on this board and other places are about “shorting” otc stocks. People that don’t sing a companies praises and chant onward and upward here daily are either bashers or shorts, that’s how it works right? Go try to short any otc and tell me how easy it is for you to pull off and how you even managed to do it.
Charles and his brother are well into their 70’s correct? Why wouldn’t you just want a complete buyout at this stage and just retire in peace and quiet with your millions. Rather than a spac deal that pushes us further out. I understand his brothers legacy might be Clone 3 and they wanted to see that through but there’s been no mention of it at all and they seem more focused on the ITV and AI and other future science. They could take a buyout and leave those things in Chandra’s hands and still have them pan out years down the road similar to how he’s been appointed ceo in one of the new subs should this SAGA deal go through. I hope it’s like some are thinking and this SAGA thing is to force others hands and bring in other offers. If not, then I hope they have something in the works to move this pps throughout the time this SAGA deal plays out. Seems like if something isn’t inked soon, we wouldn’t see those SAGA dividend shares in our accounts until almost a year from now. My last shred of hope for anything big coming the rest of this year, going into 2024 would be surprise news that we are the ones working with Regeneron on the “one in a million breakthrough” Covid mab. Or maybe a one in a million chance surprise announcement that they took a complete buyout for some large figure much higher than the SAGA amount.
They’ll fit right in here. Vague and more questions than answers.
When does SAGA have to officially file the latest extension?
They issued an 8k earlier and all it addresses is adding board members and the delinquency filing notice for Q1.
Lol finally someone said it
Lol right. The only ones unhappy with the Cybertruck delays were the ones that were foaming at the mouths over it and slapped down a huge chunk of cash to preorder. No common shareholders were pissed off about Cybertruck delays.
Tesla is about the worst example for a comparison as you can get.
So is the Cybertruck. Its so far out there, he was prob forced to alter so many things over the years to meet regulations, insurance, etc that it just kept getting delayed.
Tesla rakes in billions and has many other vehicles (product) already to market for years. One Musk over promise, under deliver in the Cybertruck, while meeting dozens of other Tesla milestones he sets, doesn’t matter.
ENZC has zero products of any value to market after 3 years of over promise, under deliver and no revenue (I’m not counting the $60 from IPF bc it’s a damn joke). If we had one medical product to market with significant revenue and another in trials right now, I think most would be happy with the progress. Like I said and have given examples on in the past, Charles and Chandra set high expectations here that were not met in the timeframes they initially gave or hinted at, and that’s why we are where we are with many disgruntled shareholders. I see the comments daily here, on twitter, stocktwits and all the other places and I’d have to say shareholder sentiment is about 75% negative right now. So I’m sure as hell not the only one voicing these things.
I’m not playing into your circle of insanity again either. Maga and I have both recently linked and listed at least a dozen examples of “over promise, under deliver” straight from Charles, Chandra or the press releases. I’m not doing your work for you again. Revisit Charles timelines in his spring 2021 emerging growth conference live podcast on YouTube as a start. Many there. And I can pick out at least a dozen alone from Chandra’s twitter and another dozen from the 2 1/2 years of press releases. Once again, facts that have been presented numerous times by myself and others here.
Once again, since your two feeble brain cells can’t connect to comprehend I’ll have to restate yet again. The problem is Charles, Chandra and the company press releases gave us the timeline expectations that were not met. They over promised and under delivered. So disgruntled shareholders are not to blame for expecting things to be further along than they currently are after nearly 3 years. Please reread this until it sinks into your pea brain once and for all.
You do realize in life people can have varying opinions about a single subject right? Lol!
Slander by saying they have constantly over promised and under delivered? That’s not slander, that’s facts. And dozens of others here have pointed out the same thing.
It’s funny that every time you claim I’m “bashing” or spreading false information, when I ask you to show the board what I’ve posted that’s false, you resort to name calling like “dumb ass”. Just like the other person said, when you back yourself into a corner in a debate and have nothing left, you resort to childish name calling.
Every single things I’ve posted here has been backed by the facts as they have played out.
The Regeneron speculation linked to us was for Covid mabs, not Clone 3. Though anything is possible at this point I guess since we’ve been in the dark on anything Clone 3 related for most of this 3 year span.
I’m still holding out hope (which is fading fast) that the Renegeron Covid mab speculation turns out to be us.
Welcome to the reality of where this is headed and what many of us had feared for awhile now. Good to see you “get it”.
The potential for our ENZC shares to “moon” is a lot greater than the potential for $10 SAGA shares to “moon” after this deal is done.
And that’s exactly what I was getting at. Glad someone else helped to clarify. I was pretty sure that they needed to start from scratch, (against what they led us to believe initially) hence why we needed the 6 week toxicity study last fall and now almost a year later only about to start a 6 month human trial on ITV-1. So much for the fast track straight to patients as they led us to believe since 2021.
As usual your reading comprehension is below pre school level. The problem as usual here is they over promised, under delivered and led us to believe a different ITV-1 timeframe would pan out than it actually turned out to be. And this has been a continual pattern here. Sad I needed to explain something to you yet again that’s clear as day and has been explained dozens of times.
What previous trial info for ITV-1 was approved towards this current situation? It’s been a year and a half since they said ITV-1 was going the quicker route through Africa which supposedly didn’t need the stringent testing. Wasn’t it last November that it needed a 6 week toxicity study? Then we waited the whole way through spring where we were told Harry was traveling to Africa to oversee the administration of ITV-1. Well, 3 months after that and we still haven’t begun yet, as last they told us it would be end of July Or August, followed by a 6 month clinical.
So again, what specific previous clinical info was used for this current situation? And how has it possibly sped things up?
You’d think so, but I guess they held the patent all those years and had no means to fund any type of trials.
Then again, they told us the Africa route for ITV-1 was being done to avoid costly up front EUA / FDA trials and get a foot in the door so to say, that would eventually lead to the bigger trials.
Well why not take that route with Clone 3? ITV-1 was supposedly just a treatment and Clone 3 touted as the “cure”. Maybe they are just doing it this way to take revenue from ITV-1 to then fund the Clone 3 trials.
That would make sense, but then why not be more clear about it? They’ve said next to nothing about Clone 3 this entire 3 year span.
Agree. I hope something big happens before this is inked that causes Charles to hold off.
If this deal stands as is and doesn’t change by the time it’s inked, and ENZC does in fact have “no assets”, “no operations” after the dividend payout, then you’re going to see the ENZC pps go back sub penny and likely to trips. There’s no other otc stocks that have 4 billion in shares and no assets or operations that are trading above trips.
Between now and then ENZC is going to have to retain an asset that isn’t included in this SAGA deal (Clone 3) or have some valuable new asset to name for this pps to hold even around this .04 level. If not, it’s done.
I’m with you on that, I can’t believe he would have included Clone 3 in this deal. Not for $450 million. But then again, I keep going back to the “no assets” quote. Well I hope I’m wrong with my take on this deal the whole time, and it stays with ENZC. At least that would be one reason for the pps to hold and not dump post dividend payout. I just can’t get past them flat out telling us “no assets” in ENZC post dividend. Clone 3 is their biggest asset.
Once the ENZC price per share is over .09 cents, then you’re basically paying over $10 for SAGA if you buy ENZC above that amount. So it makes the dividend pointless.
Well ITV-1 was never a potential “cure”. It’s only a treatment. If there was anything ground breaking with it, the world would have heard about it during prior testing. And that 2016 testing you were discussing.
Clone 3 was supposed to be the flagship here, and potential “cure”, so why have they put all their effort for 3 years into a over the counter supplement that generated $60 in revenue apparently and all the rest of the effort in ITV-1?!
They haven’t given a single update on Clone 3 since the merger nearly 3 years ago. Why not push Clone 3 first in Africa and then out to EUA approval and reciprocal FDA approval?
I invested here all those years ago for Clone 3, and this is frustrating as anything. All the effort the last 3 years should have been focused on their flagship product and finally getting it to market, not these other lesser things first.
Absolute crazy talk for a company that’s so far produced nothing but $60 in revenue. Let’s get one valid medical product to market and be realistic. Professing this is going to take over the world and be the biggest pharma ever is delusional.
That was Clone 3 like 25 years ago that Fauci tried to claim a patent on, not ITV-1.
I’m done. Someone else can attempt to get through to you.
My “theory” is based on the fact that Charles himself and the filing told us as much. That ENZC would be left with nothing post dividend payout. “No assets”, “no operations”. His words, not mine. Until I see him say otherwise, that’s what I’m going with at this point.
Let me ask you something. What did you learn from the multiple ENZC / SAGA press releases and the followup supplemental filing they released that was specifically to clarify the deal for shareholders?
I’ve seen you asking the same questions for weeks and I’ve seen GF, Mark, all of the usuals from twitter spell it out for you about a dozen times. Then you come here and many others spell it out for you as well and you ignore the answers given and talk in circles with your responses. Oracle of insanity. I’m not the first person here to point this out.
If you didn’t learn anything from the PR’s and supplemental filing, then you should have learned from the dozens of clear responses you’ve gotten here and on twitter.
I’ve seen your questions answered at least a dozen times already between here and twitter. But you just keep going in circles. I’m not really sure how else people are supposed to explain it to you.
Just wait for the 8k when this deal is inked and there will be nothing left to wonder about.
Clone 3 is a current ENZC asset, agreed?
Common shareholders are the ones who will own 90% once the dividend is paid. End of topic.
Do you really think the SEC would approve this if they were paying themselves the dividend lmao?